Nadofaragene firadenovec: a breakthrough in the field of bladder oncology.

Nadeem A, Qamar K, Bilal W, Vohra LI, Ahsan A, Tariq R

DOI: 10.3389/fruro.2023.1206398
Published: 2023
Container: Frontiers in urology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fruro.2023.1206398,
  title = {Nadofaragene firadenovec: a breakthrough in the field of bladder oncology.},
  author = {Nadeem A and Qamar K and Bilal W and Vohra LI and Ahsan A and Tariq R},
  year = {2023},
  journal = {Frontiers in urology},
  doi = {10.3389/fruro.2023.1206398},
  url = {https://doi.org/10.3389/fruro.2023.1206398}
}

RIS

TY  - JOUR
TI  - Nadofaragene firadenovec: a breakthrough in the field of bladder oncology.
AU  - Nadeem A
AU  - Qamar K
AU  - Bilal W
AU  - Vohra LI
AU  - Ahsan A
AU  - Tariq R
PY  - 2023
JO  - Frontiers in urology
DO  - 10.3389/fruro.2023.1206398
UR  - https://doi.org/10.3389/fruro.2023.1206398
ER  -

APA

A, N., K, Q., W, B., LI, V., A, A., & R, T. (2023). Nadofaragene firadenovec: a breakthrough in the field of bladder oncology.. Frontiers in urology. https://doi.org/10.3389/fruro.2023.1206398

Source records

pubmed · retrieved 2026-09-25T08:03:37.050Z